Avanos Medical (AVNS) Share-based Compensation Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.60% |
| Dec 31, 2025 | -17.81% |
| Sep 30, 2025 | 0.58% |
| Jun 30, 2025 | 6.45% |
| Mar 31, 2025 | 8.73% |
| Dec 31, 2024 | 17.45% |
| Sep 30, 2024 | -1.47% |
| Jun 30, 2024 | 16.12% |
| Mar 31, 2024 | -3.04% |
| Dec 31, 2023 | 9.86% |
| Sep 30, 2023 | 10.20% |
| Jun 30, 2023 | 13.18% |
| Mar 31, 2023 | 2.71% |
| Dec 31, 2022 | 41.71% |
| Sep 30, 2022 | 14.32% |
| Jun 30, 2022 | -5.83% |
| Mar 31, 2022 | -2.89% |
| Dec 31, 2021 | 3.71% |
| Sep 30, 2021 | 3.13% |
| Jun 30, 2021 | -8.13% |
| Mar 31, 2021 | -3.99% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -10.76% |
| Mar 31, 2020 | -14.27% |
| Dec 31, 2019 | -9.50% |
| Sep 30, 2019 | -1.37% |
| Jun 30, 2019 | 5.15% |
| Mar 31, 2019 | 43.10% |
| Dec 31, 2018 | 13.97% |